Luitpold Pharmaceuticals Inc.

• Private
• US

Dow Jones Description

At Luitpold Animal Health , we are totally committed to advancing the cause of better animal health. From multimillion-dollar thoroughbreds to long-time companion animals, the better health and well-being of horses is what we work toward every day. You've known and trusted the quality and reliability of Adequan i.m. (polysulfated glycosaminoglycan) for years. Now we invite you to look at the joint disease educational program from Luitpold Animal Health. Luitpold Animal Health puts the highest priority on quality and safety. As part of the Luitpold Pharmaceuticals, Inc. Training Program, each employee is trained on current Good Manufacturing Practices (cGMP), OSHA safety and Code of Federal Regulations, as well as company safety and security policies and quality procedures. We meet the high standards of regulation set by the Food and Drug Administration (FDA), Occupational Safety and Health Administration (OSHA), Environmental Protection Agency and Department of Transportation (DOT). Our company's standard operating procedures meet or exceed all FDA guidelines for pharmaceutical companies. "'Improve on Today,' is our working mission," says Mary Jane Helenek, Luitpold Pharmaceuticals, Inc. President and CEO. "By continuing to build on our successes, our industry involvement, our commitment, and our advocacy, we are confident we will continue to meet and exceed the expectations of our customers."

CEO

Number of Employees 400

Contact Information

Peer Companies

• McKesson Corp.
• Cardinal Health Inc.
• AmerisourceBergen Corp.
• NU Skin Enterprises Inc.
• Sciele Pharma Inc.
• All Companies